Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Doctors develop computer simulation for spleen's filtering process

Researchers have created a new computer model that is able to show how the tiny slits in the spleen filter diseased or misshapen red blood cells from re-entering the bloodstream. 

Dialysis services could get extra $50 million from CMS in 2017

Dialysis services would receive $50 million in additional Medicare reimbursements under a 0.5 percent increase included in suggested rate changes by CMS.

3-D printed cartilage may present new path toward joint rejuvenation

A research team at Penn State has developed a 3-D bioprinting process that uses strands of cow cartilage to create cartilage patches for worn out joints. 

WellCare Health Plans expands Medicaid benefits to members in Georgia

Health insurance company WellCare Health Plans enhanced its Medicaid benefits this week for members who live in Georgia as a way to encourage them to maintain healthier lives.

Experian Health launches three new revenue management systems

Revenue cycle management company Experian Health is launching three new products that will expand its portfolio of revenue systems it offers to healthcare organizations.

Dems to DOJ: Block Anthem-Cigna, Aetna-Human mergers

Seven Democratic senators asked the Department of Justice (DOJ) to challenge the pending Anthem-Cigna and Aetna-Humana mergers, arguing the consolidation of these insurers would lead to higher premiums and decreased access to care.

Medicare trustees say hospital trust fund will run dry by 2028

The annual report card from the Boards of Trustees for Medicare paints a grim financial picture for the future of the program.

McKesson considers IT merger with Change Healthcare

McKesson Corp. has been in talks about merging its information technology unit with Change Healthcare Inc., reports Reuters.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.